(3)(deleted)The Management Board is authorized to increase the share capital on or before
April 30, 2030, once or more than once, by up to a total of €1,995,000,000 through the issue
of new shares against cash payments (Authorized Capital 2025/I). Shareholders are to be
granted pre-emptive rights. However, the Management Board is authorized to except broken
amounts from shareholders’ pre-emptive rights and to exclude pre-emptive rights insofar as
is necessary to grant to the holders of option rights, convertible bonds and convertible
participatory rights issued by the company and its affiliated companies pre-emptive rights to
new shares to the extent that they would be entitled to such rights after exercising their
option or conversion rights. The Management Board may make use of the authorizations
above to exclude pre-emptive rights only to the extent that the proportional amount of the
newly issued shares with the exclusion of pre-emptive rights does not exceed 10% of the
share capital. Decisive for calculating the 10% limit is the amount of share capital at the time
this authorization becomes effective. Should the amount of share capital be lower at the time
this authorization is exercised, this amount is decisive. If, during the period of this
authorization until its utilization, use is made of other authorizations to issue company shares
or to issue rights that enable or obligate the subscription of the company’s shares and pre-
emptive rights are excluded in the process, this is to be counted towards the 10% limit
specified above. Management Board resolutions to utilize authorized capital and to exclude
pre-emptive rights require the Supervisory Board’s approval. The new shares may also be
taken up by banks specified by the Management Board with the obligation to offer them to
shareholders (indirect pre-emptive right).
(4)The Management Board is authorized to increase the share capital on or before April 30,
2026, once or more than once, by up to a total of €512,000,000 through the issue of new
shares against cash payments (Authorized Capital 2021/I). Shareholders are to be granted
pre-emptive rights. However, the Management Board is authorized to except broken
amounts from shareholders’ pre-emptive rights and to exclude pre-emptive rights insofar as
is necessary to grant to the holders of option rights, convertible bonds and convertible
participatory rights issued by the company and its affiliated companies pre-emptive rights to
new shares to the extent that they would be entitled to such rights after exercising their
option or conversion rights. The Management Board is also authorized to exclude the pre-
emptive rights in full if the issue price of the new shares is not significantly lower than the
quoted price of the shares already listed at the time of the final determination of the issue
price and the total shares issued since the authorization in accordance with § 186 (3)
sentence 4 Stock Corporation Act do not exceed 10% of the share capital at the time the
authorization becomes effective – or if the value is lower – at the time the authorization is
utilized. Shares that are issued or sold during the validity of this authorization with the
exclusion of preemptive rights, in direct or analogous application of § 186 (3) sentence 4
Stock Corporation Act, are to be included in the maximum limit of 10% of the share capital.
Also to be included are shares that are to be issued to service option and/or conversion
rights from convertible bonds, bonds with warrants, convertible participatory rights or
participatory rights, if these bonds or participatory rights are issued during the validity of this
authorization with the exclusion of pre-emptive rights in corresponding application of § 186
(3) sentence 4 Stock Corporation Act. The Management Board may make use of the
authorizations above to exclude preemptive rights only to the extent that the proportional
amount of the newly issued shares with the exclusion of pre-emptive rights does not exceed
10% of the share capital. Decisive for calculating the 10% limit is the amount of share capital
at the time this authorization becomes effective. Should the amount of share capital be lower
at the time this authorization is exercised, this amount is decisive. If, during the period of this